Pharvaris (PHVS) Interest Expenses (2020 - 2022)
Pharvaris (PHVS) reported Interest Expenses of -$67136.4 for Q4 2022, down 299.96% on a YoY basis from $33574.4 in Q4 2021, and down 355.68% quarter-over-quarter from $26257.5 in Q3 2022.
Pharvaris (PHVS) Interest Expenses (2020 - 2022) Analysis & Trends
Pharvaris has reported Interest Expenses for 3 years, with the latest figure at -$67136.4 in Q4 2022.
- For the quarter ending Q4 2022, Interest Expenses fell 299.96% year-over-year to -$67136.4; the trailing twelve-month figure through Sep 2023 stood at -$67136.4 (down 212.21% YoY), and the FY2022 full-year result was $41372.0, down 86.94% from the prior year.
- Interest Expenses for Q4 2022 stood at -$67136.4, down from $26257.5 in the prior quarter.
- The five-year high for Interest Expenses was $297037.2 in Q2 2021, with the low at -$104990.8 in Q1 2021.
- Historically, Interest Expenses has averaged $38956.3 across 3 years, with a median of $29915.9 in 2021.
- The largest YoY upside for Interest Expenses was 535.92% in 2021 against a maximum downside of 729.6% in 2021.
- Pharvaris' Interest Expenses stood at $46709.6 in 2020, then slipped by 28.12% to $33574.4 in 2021, then slumped by 299.96% to -$67136.4 in 2022.
- The last three Interest Expenses figures came in at -$67136.4 (Q4 2022), $26257.5 (Q3 2022), and $33574.4 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -67,136.36 |
| Dec 31, 2022 | -67,136.36 |
| Sep 30, 2022 | 26,257.48 |
| Sep 30, 2022 | 26,257.48 |
| Dec 31, 2021 | 33,574.40 |
| Dec 31, 2021 | 33,574.40 |
| Sep 30, 2021 | 92,854.73 |
| Sep 30, 2021 | 92,854.73 |
| Jun 30, 2021 | 297,037.16 |
| Jun 30, 2021 | 297,037.16 |
| Mar 31, 2021 | -104,990.79 |
| Mar 31, 2021 | -104,990.79 |
| Jun 30, 2020 | 46,709.62 |
| Jun 30, 2020 | 46,709.62 |
| Mar 31, 2020 | -12,655.56 |
| Mar 31, 2020 | -12,655.56 |